861 related items for PubMed ID: 26289063
1. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N, Kim S, Craig J, Hodson E.
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[Abstract] [Full Text] [Related]
2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
3. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
[Abstract] [Full Text] [Related]
4. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
5. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.
Cochrane Database Syst Rev; 2013 Oct 29; (10):CD002290. PubMed ID: 24166716
[Abstract] [Full Text] [Related]
6. Corticosteroid therapy for nephrotic syndrome in children.
Hahn D, Hodson EM, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2015 Mar 18; 2015(3):CD001533. PubMed ID: 25785660
[Abstract] [Full Text] [Related]
7. Non-corticosteroid treatment for nephrotic syndrome in children.
Durkan A, Hodson E, Willis N, Craig J.
Cochrane Database Syst Rev; 2001 Mar 18; (4):CD002290. PubMed ID: 11687155
[Abstract] [Full Text] [Related]
8. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 18; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
9. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
10. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar 04; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
11. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.
Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K.
Pediatr Nephrol; 2024 Aug 04; 39(8):2393-2401. PubMed ID: 38267591
[Abstract] [Full Text] [Related]
12. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr 04; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 04; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
14. Non-corticosteroid treatment for nephrotic syndrome in children.
Hodson EM, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002290. PubMed ID: 18254005
[Abstract] [Full Text] [Related]
15. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2003 Jan 23; (1):CD001533. PubMed ID: 12535410
[Abstract] [Full Text] [Related]
16. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2001 Jan 23; (2):CD001533. PubMed ID: 11405997
[Abstract] [Full Text] [Related]
17. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2004 Jan 23; (2):CD001533. PubMed ID: 15106158
[Abstract] [Full Text] [Related]
18. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
Health Technol Assess; 2022 Jan 23; 26(3):1-94. PubMed ID: 35060851
[Abstract] [Full Text] [Related]
19. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.
Iijima K, Sako M, Kamei K, Nozu K.
Pediatr Nephrol; 2018 Sep 23; 33(9):1449-1455. PubMed ID: 28717938
[Abstract] [Full Text] [Related]
20. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2000 Sep 23; (4):CD001533. PubMed ID: 11034723
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
